United Bank (Georgia)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
35,273
+2,948
| +9% | +$113K | 0.52% | 63 |
|
|
2025
Q1 | $1.25M | Buy |
32,325
+876
| +3% | +$33.9K | 0.52% | 59 |
|
|
2024
Q4 | $1.06M | Buy |
31,449
+5,664
| +22% | +$192K | 0.45% | 59 |
|
|
2024
Q3 | $1.05M | Buy |
25,785
+1,760
| +7% | +$71.9K | 0.49% | 58 |
|
|
2024
Q2 | $925K | Sell |
24,025
-4,293
| -15% | -$165K | 0.46% | 60 |
|
|
2024
Q1 | $1.21M | Buy |
28,318
+800
| +3% | +$34.3K | 0.62% | 53 |
|
|
2023
Q4 | $1.02M | Buy |
27,518
+670
| +2% | +$24.8K | 0.56% | 55 |
|
|
2023
Q3 | $973K | Buy |
26,848
+885
| +3% | +$32.1K | 0.58% | 55 |
|
|
2023
Q2 | $925K | Sell |
25,963
-645
| -2% | -$23K | 0.53% | 61 |
|
|
2023
Q1 | $947K | Buy |
26,608
+6,469
| +32% | +$230K | 0.55% | 60 |
|
|
2022
Q4 | $708K | Buy |
+20,139
| New | +$708K | 0.43% | 68 |
|
|
2018
Q3 | – | Sell |
-4,252
| Closed | -$214K | – | 78 |
|
|
2018
Q2 | $214K | Sell |
4,252
-503
| -11% | -$25.3K | 0.18% | 70 |
|
|
2018
Q1 | $232K | Sell |
4,755
-1,108
| -19% | -$54.1K | 0.21% | 69 |
|
|
2017
Q4 | $260K | Sell |
5,863
-2,121
| -27% | -$94.1K | 0.22% | 67 |
|
|
2017
Q3 | $405K | Sell |
7,984
-687
| -8% | -$34.8K | 0.38% | 61 |
|
|
2017
Q2 | $467K | Sell |
8,671
-1,133
| -12% | -$61K | 0.43% | 61 |
|
|
2017
Q1 | $517K | Sell |
9,804
-33
| -0.3% | -$1.74K | 0.49% | 60 |
|
|
2016
Q4 | $474K | Buy |
+9,837
| New | +$474K | 0.48% | 59 |
|